CIK: 0001534261 · Show all filings
Period: Q2 2022 (← Previous) (Next →)
Filing Date: Aug 15, 2022
Total Value ($000): $1,182,711 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | EQRX INC | 39,527,669 | $185,385 | 15.7% | $6.82 | — | COM | 26886C107 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 805,000 | $117,409 | 9.9% | $110.93 | +27.9% | COM | 02043Q107 |
| BLFS | BIOLIFE SOLUTIONS INC | 7,566,292 | $104,490 | 8.8% | $20.20 | -27.4% | COM NEW | 09062W204 |
| RLAY | RELAY THERAPEUTICS INC | 4,068,574 | $68,149 | 5.8% | $36.64 | -41.5% | COM | 75943R102 |
| MXCT | MAXCYTE INC | 13,971,334 | $66,084 | 5.6% | $15.08 | -67.3% | COM | 57777K106 |
| — | BLUEPRINT MEDICINES CORP | 1,150,000 | $58,087 | 4.9% | $5615.52 | — | COM | 09627Y109 |
| — | SOMALOGIC INC | 12,389,082 | $55,999 | 4.7% | $12.39 | — | CLASS A COM | 83444K105 |
| FATE | FATE THERAPEUTICS INC | 2,100,000 | $52,038 | 4.4% | $17.49 | +57.7% | COM | 31189P102 |
| SRPT | SAREPTA THERAPEUTICS INC | 650,000 | $48,724 | 4.1% | $96.09 | -23.4% | COM | 803607100 |
| — | VERVE THERAPEUTICS INC | 3,138,167 | $47,951 | 4.1% | $59.51 | — | COM | 92539P101 |
| RVMD | REVOLUTION MEDICINES INC | 2,370,000 | $46,191 | 3.9% | $30.43 | -36.0% | COM | 76155X100 |
| DNLI | DENALI THERAPEUTICS INC | 1,500,000 | $44,145 | 3.7% | $29.40 | -10.9% | COM | 24823R105 |
| IPSC | CENTURY THERAPEUTICS INC | 3,206,380 | $26,934 | 2.3% | $25.37 | -61.3% | COM | 15673T100 |
| ABSI | ABSCI CORPORATION | 7,718,593 | $25,626 | 2.2% | $19.41 | -74.4% | COM | 00091E109 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 800,000 | $25,560 | 2.2% | $34.62 | — | COM | 37890U108 |
| — | SEMA4 HOLDINGS CORP | 16,437,500 | $20,711 | 1.8% | $3.19 | — | COM CL A | 81663L101 |
| TNYA | TENAYA THERAPEUTICS INC | 3,586,818 | $20,194 | 1.7% | $21.49 | -62.3% | COM | 87990A106 |
| EXAS | EXACT SCIENCES CORP | 450,000 | $17,726 | 1.5% | $126.85 | -57.8% | COM | 30063P105 |
| TWST | TWIST BIOSCIENCE CORP | 500,000 | $17,480 | 1.5% | $33.59 | +5.4% | COM | 90184D100 |
| AGIO | AGIOS PHARMACEUTICALS INC | 785,000 | $17,403 | 1.5% | $45.91 | -50.8% | COM | 00847X104 |
| TNGX | TANGO THERAPEUTICS INC | 3,500,000 | $15,855 | 1.3% | $11.99 | -49.5% | COM | 87583X109 |
| BEAM | BEAM THERAPEUTICS INC | 375,000 | $14,516 | 1.2% | $69.31 | -42.7% | COM | 07373V105 |
| GH | GUARDANT HEALTH INC | 272,500 | $10,993 | 0.9% | $103.43 | -52.1% | COM | 40131M109 |
| — | KARUNA THERAPEUTICS INC | 85,000 | $10,753 | 0.9% | $126.51 | — | COM | 48576A100 |
| — | 2SEVENTY BIO INC | 614,754 | $8,115 | 0.7% | $17.06 | — | COMMON STOCK | 901384107 |
| ABCL | ABCELLERA BIOLOGICS INC | 750,000 | $7,988 | 0.7% | $8.47 | 0.0% | COM | 00288U106 |
| — | EXSCIENTIA PLC | 663,900 | $7,230 | 0.6% | $19.76 | — | ADS | 30223G102 |
| — | MIRATI THERAPEUTICS INC | 97,000 | $6,512 | 0.6% | $82.22 | — | COM | 60468T105 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 510,882 | $4,940 | 0.4% | $20.37 | -50.7% | COM | 61225M102 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 165,000 | $4,448 | 0.4% | $29.04 | 0.0% | COM NEW | 15117B202 |
| PMVP | PMV PHARMACEUTICALS INC | 300,000 | $4,275 | 0.4% | $14.55 | 0.0% | COM | 69353Y103 |
| SGMO | SANGAMO THERAPEUTICS INC | 1,000,000 | $4,140 | 0.4% | $4.32 | 0.0% | COM | 800677106 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 555,455 | $3,877 | 0.3% | $40.71 | -76.1% | COM | 35104E100 |
| — | SINGULAR GENOMICS SYSTEMS IN | 865,722 | $3,307 | 0.3% | $27.48 | — | COM | 82933R100 |
| — | MAGENTA THERAPEUTICS INC | 2,415,000 | $2,898 | 0.2% | $1427.81 | — | COM | 55910K108 |
| ORIC | ORIC PHARMACEUTICALS INC | 601,515 | $2,695 | 0.2% | $30.04 | -86.7% | COM | 68622P109 |
| — | INVITAE CORP | 1,038,388 | $2,534 | 0.2% | $2864.61 | — | COM | 46185L103 |
| — | SCIENCE 37 HOLDINGS INC | 225,000 | $452 | 0.0% | $12.47 | — | COM | 808644108 |
| — | KRONOS BIO INC | 123,839 | $451 | 0.0% | $29.87 | — | COM | 50107A104 |
| LIANY | LIANBIO | 206,415 | $446 | 0.0% | $6.16 | — | SPONSORED ADS | 53000N108 |